Effect of giving Zinc in Nephrotic Syndrome
Not Applicable
- Conditions
- Health Condition 1: N040- Nephrotic syndrome with minor glomerular abnormality
- Registration Number
- CTRI/2021/03/031908
- Lead Sponsor
- MLN Medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
all new and relapse cases of steroid sensitive nephrotic syndrome
Exclusion Criteria
1. patients with chronic debilitating illness
2. steroid resistant nephrotic syndrome
3. congenital malformation of genitourinary system
4. those who have taken Zinc in any form in previous 3 months
5. patients with signs of systemic infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Compare the time duration to next relapse in those supplemental with Zinc for 2 weeks and in those supplemented for 4 weeksTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method number of infective episodesTimepoint: 6 months;number of relapsesTimepoint: 6 months;time duration to attain remissionTimepoint: 1 year